Teva Pharmaceuticals, USA, Inc. v. Leavitt

296 F. App'x 75
CourtCourt of Appeals for the D.C. Circuit
DecidedSeptember 12, 2008
DocketNo. 08-5141
StatusPublished

This text of 296 F. App'x 75 (Teva Pharmaceuticals, USA, Inc. v. Leavitt) is published on Counsel Stack Legal Research, covering Court of Appeals for the D.C. Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Teva Pharmaceuticals, USA, Inc. v. Leavitt, 296 F. App'x 75 (D.C. Cir. 2008).

Opinion

JUDGMENT

PER CURIAM.

This cause came to be heard on the record on appeal from the United States District Court for the District of Columbia and on the brief and oral argument of the parties. On consideration thereof, and as will be explained more fully in an opinion to be filed at a later date, it is

ORDERED AND ADJUDGED that the injunction entered by the district court on April 11, 2008 be vacated, and the order of the district court be reversed.

The Clerk is directed to issue the mandate forthwith.

Free access — add to your briefcase to read the full text and ask questions with AI

Cite This Page — Counsel Stack

Bluebook (online)
296 F. App'x 75, Counsel Stack Legal Research, https://law.counselstack.com/opinion/teva-pharmaceuticals-usa-inc-v-leavitt-cadc-2008.